Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ASTRAZENECA PHARMA vs CIPLA - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ASTRAZENECA PHARMA CIPLA ASTRAZENECA PHARMA/
CIPLA
 
P/E (TTM) x 95.9 32.3 297.3% View Chart
P/BV x 22.8 5.2 440.6% View Chart
Dividend Yield % 0.3 0.6 52.7%  

Financials

 ASTRAZENECA PHARMA   CIPLA
EQUITY SHARE DATA
    ASTRAZENECA PHARMA
Mar-23
CIPLA
Mar-23
ASTRAZENECA PHARMA/
CIPLA
5-Yr Chart
Click to enlarge
High Rs3,6201,185 305.4%   
Low Rs2,438852 286.1%   
Sales per share (Unadj.) Rs401.2281.9 142.3%  
Earnings per share (Unadj.) Rs39.735.1 113.1%  
Cash flow per share (Unadj.) Rs46.249.7 93.1%  
Dividends per share (Unadj.) Rs16.008.50 188.2%  
Avg Dividend yield %0.50.8 63.3%  
Book value per share (Unadj.) Rs234.4289.2 81.1%  
Shares outstanding (eoy) m25.00807.15 3.1%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x7.53.6 208.9%   
Avg P/E ratio x76.329.0 263.0%  
P/CF ratio (eoy) x65.520.5 319.4%  
Price / Book Value ratio x12.93.5 366.8%  
Dividend payout %40.324.2 166.5%   
Avg Mkt Cap Rs m75,718822,164 9.2%   
No. of employees `000NANA-   
Total wages/salary Rs m2,59138,301 6.8%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m10,030227,531 4.4%  
Other income Rs m2615,121 5.1%   
Total revenues Rs m10,291232,653 4.4%   
Gross profit Rs m1,24948,079 2.6%  
Depreciation Rs m16311,721 1.4%   
Interest Rs m61,095 0.6%   
Profit before tax Rs m1,34140,384 3.3%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m34812,029 2.9%   
Profit after tax Rs m99328,355 3.5%  
Gross profit margin %12.521.1 58.9%  
Effective tax rate %26.029.8 87.1%   
Net profit margin %9.912.5 79.4%  
BALANCE SHEET DATA
Current assets Rs m9,359168,051 5.6%   
Current liabilities Rs m4,84450,333 9.6%   
Net working cap to sales %45.051.7 87.0%  
Current ratio x1.93.3 57.9%  
Inventory Days Days4973 67.5%  
Debtors Days Days397 601.2%  
Net fixed assets Rs m2,061117,318 1.8%   
Share capital Rs m501,614 3.1%   
"Free" reserves Rs m5,811231,845 2.5%   
Net worth Rs m5,861233,460 2.5%   
Long term debt Rs m00-   
Total assets Rs m11,421290,067 3.9%  
Interest coverage x213.937.9 564.8%   
Debt to equity ratio x00-  
Sales to assets ratio x0.90.8 112.0%   
Return on assets %8.710.2 86.2%  
Return on equity %16.912.1 139.5%  
Return on capital %23.017.8 129.4%  
Exports to sales %022.6 0.0%   
Imports to sales %37.48.9 420.8%   
Exports (fob) Rs mNA51,516 0.0%   
Imports (cif) Rs m3,74720,202 18.5%   
Fx inflow Rs m61264,282 1.0%   
Fx outflow Rs m3,74720,202 18.5%   
Net fx Rs m-3,13544,080 -7.1%   
CASH FLOW
From Operations Rs m58332,377 1.8%  
From Investments Rs m181-23,885 -0.8%  
From Financial Activity Rs m-245-9,583 2.6%  
Net Cashflow Rs m519-968 -53.6%  

Share Holding

Indian Promoters % 0.0 13.4 -  
Foreign collaborators % 75.0 20.0 374.3%  
Indian inst/Mut Fund % 5.4 50.0 10.8%  
FIIs % 2.7 25.7 10.3%  
ADR/GDR % 0.0 0.0 -  
Free float % 25.0 66.5 37.6%  
Shareholders   29,032 425,731 6.8%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ASTRAZENECA PHARMA With:   SUN PHARMA    DIVIS LABORATORIES    DR. REDDYS LAB    ZYDUS LIFESCIENCES    MANKIND PHARMA    


More on ASTRAZENECA PHARMA vs Cipla

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

ASTRAZENECA PHARMA vs Cipla Share Price Performance

Period ASTRAZENECA PHARMA Cipla S&P BSE HEALTHCARE
1-Day 0.47% 2.05% 1.31%
1-Month -3.17% 1.36% -0.62%
1-Year 59.94% 68.21% 62.03%
3-Year CAGR 20.69% 22.58% 18.21%
5-Year CAGR 22.30% 23.26% 19.82%

* Compound Annual Growth Rate

Here are more details on the ASTRAZENECA PHARMA share price and the Cipla share price.

Moving on to shareholding structures...

The promoters of ASTRAZENECA PHARMA hold a 75.0% stake in the company. In case of Cipla the stake stands at 33.5%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of ASTRAZENECA PHARMA and the shareholding pattern of Cipla.

Finally, a word on dividends...

In the most recent financial year, ASTRAZENECA PHARMA paid a dividend of Rs 16.0 per share. This amounted to a Dividend Payout ratio of 40.3%.

Cipla paid Rs 8.5, and its dividend payout ratio stood at 24.2%.

You may visit here to review the dividend history of ASTRAZENECA PHARMA, and the dividend history of Cipla.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 550 Points| Nifty Tops 22,250 | Power Stocks Shine Sensex Today Rallies 550 Points| Nifty Tops 22,250 | Power Stocks Shine(10:30 am)

Asian markets traded lower, while the US stock indices ended higher overnight with the S&P 500 hitting a record closing high ahead of key economic data.